Last Update 02 Jul 26
Fair value Decreased 8.58%1508: Board Changes And Dividend Visibility Will Support A Steady Outlook
Analysts have trimmed their HK$ price target for China Reinsurance (Group), citing revised assumptions that include a lower fair value estimate, a higher discount rate, and adjusted expectations for revenue growth, profit margins, and future P/E multiples.
What's in the News
- China Reinsurance (Group) shareholders approved a 2025 final dividend of RMB 0.0691 per share, with a total cash distribution of RMB 2.935b, scheduled for payment on 21 August 2026 to shareholders on the register as of 8 July 2026.
- The 2025 final dividend will be paid in Renminbi to domestic shareholders and in Hong Kong dollars to H shareholders, using an exchange rate of HK$1 = RMB 0.869674. This results in a final dividend of HK$0.079455 per H share, according to the company's shareholder meeting documents.
- At a board meeting on 29 May 2026, China Reinsurance (Group) considered and approved the nomination of Zhang Xueyong as an independent non executive director candidate for the fifth session of the board, alongside other board matters.
- At a special shareholders meeting on 29 April 2026 in Beijing, investors considered and approved the election of He Xingda as a non executive director for the fifth session of the board of directors of China Reinsurance (Group).
Valuation Changes for China Reinsurance (Group)
- Fair Value: The fair value estimate has been revised from HK$1.73 to HK$1.59, reflecting a trimmed valuation estimate for China Reinsurance (Group).
- Discount Rate: The discount rate assumption has risen slightly from 8.11% to 8.59%, indicating a higher required return in the updated model.
- Revenue Growth: The CN¥ revenue growth assumption has moved from 7.08% to 8.88%, indicating higher expected topline expansion in the latest set of assumptions.
- Profit Margin: The CN¥ net profit margin assumption has been reduced from 10.31% to 8.91%, pointing to more conservative profitability expectations.
- Future P/E: The assumed future P/E multiple has edged down from 6.36x to 6.02x, implying a slightly lower valuation multiple being applied to China Reinsurance (Group).
Key Takeaways
- Innovative products in climate change and EV insurance could enhance revenue by addressing unmet demand and emerging risks.
- Focus on digital transformation and global expansion may improve operational efficiency and boost revenue growth in strategic regions.
- Competitive global market, domestic interest rate drops, and climate risks threaten growth, market share, and profitability despite optimism about long-term trends.
Catalysts
About China Reinsurance (Group)- Operates as a reinsurance company in the People's Republic of China and internationally.
- China Reinsurance is focusing on new product innovations in areas such as climate change and EV insurance, which could enhance future revenue streams by tapping into unmet market demand and mitigating emerging risks.
- The company's efforts in leveraging technology for digital transformation and precise risk management are likely to improve operational efficiency and could lead to higher net margins through cost management and better pricing accuracy.
- The firm is actively pursuing global expansion, aiming to grow its international presence and increase its market share from 4% of the global reinsurance market, which may boost overall revenue growth as international operations expand in strategic regions.
- China Reinsurance is committed to long-term, value-based investments, with a focus on stable, high-dividend-yield sectors like technology and AI, potentially increasing total investment returns and overall earnings, even in a low domestic interest rate environment.
- The company anticipates growth in its primary and reinsurance segments, particularly life and health insurance driven by domestic demand and regulatory changes, which could bolster consolidated revenue and improve profit margins.
China Reinsurance (Group) Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming China Reinsurance (Group)'s revenue will grow by 8.9% annually over the next 3 years.
- Analysts assume that profit margins will shrink from 9.1% today to 8.9% in 3 years time.
- Analysts expect earnings to reach CN¥12.4 billion (and earnings per share of CN¥0.29) by about July 2029, up from CN¥9.8 billion today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as CN¥14.3 billion.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 6.0x on those 2029 earnings, up from 4.1x today. This future PE is lower than the current PE for the HK Insurance industry at 6.1x.
- Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 8.59%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- The domestic interest rate in China has been dropping, which creates pressure on achieving attractive investment returns and could negatively impact net margins and earnings.
- The global reinsurance market is highly competitive, with major international players having a significant presence in China, which may limit the company's ability to increase its market share and revenue.
- Climate change poses significant risks, as natural disasters could result in high claims and impact net margins if not properly mitigated with effective risk management strategies.
- The company faces challenges related to innovation and diversification in the global market, with a relatively small share of the international reinsurance market, potentially impacting long-term revenue growth.
- While the company is optimistic about long-term economic trends, uncertainties in both domestic and international markets remain, which could affect future revenue and profitability projections.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of HK$1.59 for China Reinsurance (Group) based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of HK$1.92, and the most bearish reporting a price target of just HK$1.33.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be CN¥139.3 billion, earnings will come to CN¥12.4 billion, and it would be trading on a PE ratio of 6.0x, assuming you use a discount rate of 8.6%.
- Given the current share price of HK$1.09, the analyst price target of HK$1.59 is 31.3% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on China Reinsurance (Group)?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.